Back
Recursion Pharmaceuticals Vs. Pfizer Industry Stock Comparison
Sell
44
RXRX
Recursion Pharmaceuticals
Last Price:
6.81
Seasonality Move:
-13.67%
Sell
30
PFE
Pfizer
Last Price:
29.41
Seasonality Move:
4.71%
Sell
44
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy, Sell or Hold?
- The current Recursion Pharmaceuticals [RXRX] share price is $6.81. The Score for RXRX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- RXRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Pfizer (PFE)
is a Sell
Is Pfizer a Buy, Sell or Hold?
- The current Pfizer [PFE] share price is $29.42. The Score for PFE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- PFE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RXRX Stock Price Chart
What is Recursion Pharmaceuticals's stock price today?
-
The Recursion Pharmaceuticals share price today is $6.81
The current trend is relatively stagnant and RXRX is experiencing slight buying pressure.
PFE Stock Price Chart
RXRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 49.62 | Sell |
| Chaikin Money Flow: | 325985 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.3 - 7.44) | Sell |
| Bollinger Bands (100): | (6.84 - 9.02) | Sell |
PFE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 52.44 | Buy |
| Chaikin Money Flow: | 10400247 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.57 - 29.57) | Buy |
| Bollinger Bands (100): | (27.83 - 29.67) | Buy |
RXRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.7 | Buy |
| 20-day SMA: | 6.78 | Buy |
| 50-day SMA: | 7.17 | Sell |
| 200-day SMA: | 9.05 | Sell |
| 8-day EMA: | 6.73 | Buy |
| 20-day EMA: | 6.75 | Buy |
| 50-day EMA: | 7.14 | Sell |
| 200-day EMA: | 8.27 | Sell |
PFE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.6 | Sell |
| 20-day SMA: | 29.14 | Buy |
| 50-day SMA: | 29.36 | Buy |
| 200-day SMA: | 28.13 | Buy |
| 8-day EMA: | 29.53 | Sell |
| 20-day EMA: | 29.31 | Buy |
| 50-day EMA: | 29.09 | Buy |
| 200-day EMA: | 29.5 | Sell |
Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.17 per share, an increase this year of $0.09 per share, and a decrease next year of $0.16 per share.
Pfizer Earnings Growth & PFE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.93 per share, an increase next quarter of $0.06 per share, an increase this year of $1.11 per share, and an increase next year of $0.22 per share.
Recursion Pharmaceuticals Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pfizer Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||